Navigation Links
Acuo Emerges in KLAS Study as Prime Example of Provider Image Archiving Interoperability
Date:8/30/2012

BLOOMINGTON, Minn., Aug. 30, 2012 /PRNewswire/ -- Acuo Technologies®, the world leader in high-performance software and services for clinical content management and data migration, announced today that KLAS recently released the results of a new study focused on enterprise imaging strategies among U.S. healthcare providers. These organizations are at various stages of addressing federal meaningful use requirements, including "getting the right image to the right place at the right time" in order to enhance quality of care, improve patient outcomes and reduce healthcare costs.

According to the study, vendor neutral archive (VNA) strategies are becoming more popular. In describing the advantage of a VNA, the report stated "a VNA's true advantage is that it is agnostic, interoperable, and in theory can more effectively manage, archive, and distribute images and clinical media regardless of vendor, device origin, or content format." Of providers interviewed by KLAS for the study, 27% indicated that a VNA would be central to their enterprise imaging strategy (selected most often by hospitals with more than 500 beds).

The KLAS report, entitled "Enterprise Imaging 2012: Provider Strategies and Insights," identified Acuo Technologies as a VNA market pioneer, saying the company "works well with a myriad of imaging vendors." An Acuo client interviewed for the study commented that "Acuo is our long-term vendor neutral archive. All of our imaging systems in the institution now use Acuo as their long-term storage." The report further elaborated that "Acuo's [Universal Clinical Platform] technology is being used in radiology for cardiac cath, echo, EKG, and radiation oncology across vendors like GE, Siemens and Philips," citing the scenario as "a prime example of what providers hope an interoperable image archive can do for them."

"Acuo's KLAS performance results are a testament to the hard work and commitment by our team over the past twelve years, assisting healthcare organizations to become proficient at accessing and controlling clinical data previously held captive in PACS archives," said Jeff Timbrook, CEO of Acuo Technologies. "Our Universal Clinical Platform is a truly PACS-independent solution that unlocks the value of provider data. It extracts rich clinical content from departmental silos so that clinical images and related content become more liquid, making them easier to move to the point of need. A PACS-agnostic archive ultimately gives healthcare organizations greater choice and flexibility when it comes to executing the best clinical, business and technology strategies that benefit patients, providers and other stakeholders."  

The report mentioned Acuo's increasing number of vendor partnerships and growing VNA mindshare in suggesting Acuo as a "viable archive option for those that do not want to solely rely on a PACS archive." Acuo strengths highlighted in the report include VNA capabilities, strength in routing, distributing and managing images, experience in PACS data migration and ability to work with multiple PACS vendors across different departments.  For more information on this report, visit www.KLASresearch.com

About Acuo Technologies

Acuo Technologies, with headquarters in Minneapolis, MN, was founded in 2000 with the objective of developing the first enterprise-wide collaborative Universal Clinical Platform (UCP) solution for medical image content, both DICOM and Non-DICOM. Today, Acuo supports implementations of UCP around the world, including locations in Africa, Australia, Europe, North America and South America. For more information on providing superior clinical content management and data migration while simplifying operations and reducing costs, visit www.acuotech.com.

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.


'/>"/>
SOURCE Acuo Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
2. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
3. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
4. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
5. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
6. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
7. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
8. Staffing and Performance Benchmarks for Regulatory Function Highlight New Medical Device Study
9. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
10. New In Vitro Study Data Show That Wound Dressing With Silver Kills Multidrug-Resistant Organisms
11. Unprecedented Study shows Berlin Heart device provides life-saving "bridge" for young children and babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):